Danaher Corp (DHR) Insider Sells 850,000 Shares

2 min readBy Investing Point

RALES MITCHELL P, an insider at Danaher Corp (DHR), sold 850,000 shares of the company on November 24, 2025, at a price of $231.19 per share, resulting in a total transaction value of $196.51 million. Following this sale, RALES MITCHELL P retains 850,000 shares of the company.

Danaher Corp operates in the Life Sciences Tools & Services industry and is headquartered in Washington, D.C. The company employs 61,000 full-time staff and is structured into three segments: Biotechnology, Life Sciences, and Diagnostics. The Biotechnology segment focuses on the development and delivery of biological medicines, while the Life Sciences segment provides tools for studying the fundamental building blocks of life. The Diagnostics segment offers critical instruments and services for disease diagnosis.

As of November 27, 2025, Danaher Corp has a market capitalisation of $161.4 billion, a P/E ratio of 46.07, and an EPS of 4.86. The company also has a dividend yield of 56.0%. Looking ahead, earnings are expected on April 20, 2026, with an EPS estimate of $2.02 and revenue forecasted at $6.1 billion.

Insider transactions, such as this sale, must be reported to the SEC, offering transparency regarding how executives view their company’s stock. While such sales can occur for various reasons—including diversification or personal financial needs—they do not necessarily indicate negative sentiment toward the company. Investors are advised to consider broader patterns of insider activity rather than isolated transactions when evaluating such signals.

This brief was generated from structured financial data and reviewed by the Investing Point editorial team. It is for informational purposes only and does not constitute investment advice. Market data provided by Finnhub.

Related Stocks

More in this Category

Insider Trades

Explore more insider trades or view detailed analysis for DHR stock.